Cenegermin
Orphan Drug Cold Chain RequiredFDA Approved
Contents
Description
Cenegermin is a recombinant human nerve growth factor (rhNGF) used to treat neurotrophic keratitis. It promotes corneal healing.
Indications & Therapeutic Use
Neurotrophic keratitis
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Cenegermin — GNH India
4 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Cenegermin products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Cenegermin
| Generic Name | Cenegermin |
| Brands | 1 brand available |
| Active Ingredient | Cenegermin-bkbj |
| Drug Class | Neurotrophic keratitis |
| Manufacturer | Dompé farmaceutici S.p.A. |
| Dosage Forms | Ophthalmic solution |
| Medical Code | S01XA24 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 21 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02648350 |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes